Dr Wallis is a neuroscientist and brings over 12 years of global expertise in clinical development. spanning pre clinical through to Phase 3 drug and device development. She has a proven track record in managing multi site, international clinical studies across the US, Europe, Australia, and New Zealand, with a strong focus on regulatory submissions and compliance, cross-functional collaboration, and vendor management.
Prior to joining PharmAust, Dr Wallis provided clinical development consulting services to both private and public biotechnology companies in Australia, with a focus on central nervous system diseases. Her extensive experience includes roles such as Clinical Trials Program Specialist at the Australian Clinical Trials Alliance, Vice President of Clinical Operations at Lateral Pharma Biotech, and Clinical Project Manager at Orygen Youth Mental Health Research.
Dr Wallis holds a PhD from The University of Melbourne/The Florey, where her research focused on understanding the pathogenesis of MND/ALS and Alzheimer’s Disease.
